Profile
Yves Lévy is the founder of Linkinvax SA, serving as Chief Scientific Officer since 2020.
Mr. Lévy is currently the Director at Global HIV Vaccine Enterprise.
Formerly, Mr. Lévy was the Chairman & Chief Executive Officer at Institut National de la Santé & de la Recherche Médicale.
Yves Lévy active positions
| Companies | Position | Start |
|---|---|---|
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Develops preventive HIV vaccines | Director/Board Member | - |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company to develops disrupt vaccine using a unique dendritic cell-targeting vaccine platform | Founder | 2019-12-31 |
Former positions of Yves Lévy
| Companies | Position | End |
|---|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Develops preventive HIV vaccines | Commercial Services |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company to develops disrupt vaccine using a unique dendritic cell-targeting vaccine platform | Commercial Services |
- Stock Market
- Insiders
- Yves Lévy
















